Science AI Journal
Medicine · Research topic

Open research questions in Autoimmune Neurological Disorders and Treatments

26 unresolved questions extracted from the limitations and future-work sections of 256 Autoimmune Neurological Disorders and Treatments papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Growing evidence implicates immune-mediated mechanisms as central drivers of NORSE; however, existing studies have focused predominantly on innate immune dysregulation, including cytokine-driven neuroinflammation and microglial activation, whilst the role of adaptive immune mechanisms in AIE-mediated NORSE remains relatively underexplored.

    Adaptive immune dysregulation drives new-onset refractory status epilepticus · 2026 · DOI

  • Further studies investigating the immunopathogenesis of copine-5-related AIE as well as the potential significance of anti-copine-5 as a novel serological marker and of copine-5 as a potential histo- pathological tumor marker in patients with suspected melanoma are warranted.

    Copine-5-IgG-related autoimmune encephalitis: a novel paraneoplastic neurological syndrome with a strong melanoma association · 2026 · DOI

  • Neuroimmunological overlap syndromes involving optic neuritis, myelitis, and connective tissue disorders (CTDs) represent a rapidly evolving field at the intersection of neurology, immunology, and sys- tems biology. Despite significant advances in understanding patho- physiology and improving targeted therapies, major challenges remain in early diagnosis, disease stratification, and prevention of irreversible neurological damage. Future progress is expected to be driven by advances in neuroimmune therapeutics, personalized medicine, and integrative multi-omics and artificial intelligence (AI)-based approaches.

    Neuroimmunological overlap syndromes in optic neuritis, myelitis, and connective tissue diseases · 2026 · DOI

  • While published studies have suggested autoantibodies are common in PANS patients, the molecular targets of these autoantibodies (AAbs) remain poorly characterized.

    Interferon-λ-neutralizing autoantibodies and common autoimmune disease autoantibodies in pediatric acute-onset neuropsychiatric syndrome · 2026 · DOI

  • When provisional investigations such as MRI, EEG, and CSF analysis are inconclusive, clinicians should not dismiss the possibility of autoimmune encephalitis.

    Developmental Regression and Seizures in a 28-Month-Old Child: A Delayed Diagnosis of Anti-N-Methyl-D-Aspartate Receptor Encephalitis · 2026 · DOI

  • Future directions and clinical implications cur- rently, there are no FDA-approved treatments for anti-NMDAR encephalitis, and prospective multicenter clinical trials are lacking.

    Autoimmune Encephalitis with Neuropsychiatric Manifestations Secondary to Anti-NMethyl-D-Aspartate Receptor Antibodies: A Comprehensive Case Analysis and Literature Review · 2026 · DOI

  • Instead, a rigorous clinical evaluation, potentially supported by tools like the STAM3mP score, might acceptably limit the number of missed AE cases among patients suffering from memory impairment, but further studies on pre-screening biomarkers are warranted.

    Screening 1021 Swedish memory clinic visitors for autoantibody-mediated encephalitis · 2026 · DOI

  • Oneiric stupor, characterized by stereotyped gestures mimicking everyday activities, is a core manifestation of agrypnia excitata but has only rarely been reported in association with LGI1 encephalitis.

    Oneiric stupor as a clinical manifestation of LGI1 antibody-associated autoimmune encephalitis: a case report · 2026 · DOI

  • The phenotypic spectrum of anti-mGluR5 autoimmune encephalitis (AE) and the relationship between MRI findings and clinical presentations remain to be fully elucidated.

    Clinical features of anti-mGluR5 encephalitis and comparison according to MRI positivity: a systematic review and analysis · 2026 · DOI

  • Middle East Current Psychiatry (2026) 33:43 Page 7 of 8 the study sample was exclusively Egyptian, which less- ens the possibility of ethnic variability, requiring cau- tious interpretation of the results; and (3) the underlying mechanisms governing the association of anti-GAD65 antibodies and T2D in patients with schizophrenia were not investigated, calling for additional cellular research.

    Clinical significance of serum anti-GAD65 titer in patients with schizophrenia and type2 diabetes mellitus · 2026 · DOI

  • The case represents an uncommon presentation of ALE where most investigations were unremarkable, highlighting the need for better diagnostic criteria for atypical…

    Uncommon presentation of autoimmune limbic encephalitis: a case report · 2026 · DOI

  • Clinically, three of four patients (no data were available for the fourth patient) developed subacute neuropsychiatric symptoms includ- ing memory impairment, confusion and disorientation, psychosis, apathy, altered consciousness, and generalized seizures.

    Copine-5-IgG-related autoimmune encephalitis: a novel paraneoplastic neurological syndrome with a strong melanoma association · 2026 · DOI

  • In four patients, available clinical information was insufficient to clarify if the antibodies were related to an ongoing or past encephalitis or lacked relevance, with a further three considered false positive.

    Screening 1021 Swedish memory clinic visitors for autoantibody-mediated encephalitis · 2026 · DOI

  • The ABs against cell surface antigens and GAD65 should be examined directly in serum and CSF.

    Autoantikörper-assoziierte schizophreniforme Psychosen: Pathophysiologie, Diagnostik und Therapie · 2019 · DOI

  • The full extent of these groups is not yet known, and it seems not impossible that infection with a virus of attenuated virulence might produce a condition similar in many ways to poliomyelitis but differing in certain Alternatively, is it features, and particularly in course.

    Mesencephalitis and Rhombencephalitis · 1951 · DOI

Most-cited papers in Autoimmune Neurological Disorders and Treatments

Most recent work

Find a gap in your own Autoimmune Neurological Disorders and Treatments sub-topic

This page shows what the Autoimmune Neurological Disorders and Treatments literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Substance Abuse Treatment and Outcomes
989 open questions
Artificial Intelligence in Healthcare and Education
607 open questions
Attention Deficit Hyperactivity Disorder
448 open questions
Physical Activity and Health
436 open questions
Smoking Behavior and Cessation
402 open questions
Innovations in Medical Education
364 open questions
Dementia and Cognitive Impairment Research
363 open questions
HIV/AIDS Research and Interventions
342 open questions
26 open questions have been extracted from the limitations and future-work passages of 256 Autoimmune Neurological Disorders and Treatments papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.